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Abstract
Background The Patient-reported Outcome Measurement
Information System (PROMIS) continues to be an impor-
tant universal patient-reported outcomes measure (PROM)
in orthopaedic surgery. However, there is concern about
the performance of the PROMIS as a general health ques-
tionnaire in hand surgery compared with the performance of
region- and condition-specific PROMs such as theMichigan
Hand Questionnaire (MHQ) and the Boston Carpal Tunnel
Questionnaire (BCTQ), respectively. To ensure that
PROMIS domains capture patient-reported outcomes to the
same degree as region- and condition-specific PROMs do,
comparing PROM performance is necessary.
Questions/purposes (1) Which PROMs demonstrate high
responsiveness among patients undergoing carpal tunnel
release (CTR)? (2) Which of the PROMIS domains
(Physical Function [PF], Upper Extremity [UE], and Pain
Interference [PI]) demonstrate concurrent validity with the
HHQ and BCTQ domains?
Methods In this prospective study, between November
2014 and October 2016, patients with carpal tunnel syn-
drome visiting a single surgeon who elected to undergo
CTR completed the BCTQ, MHQ, and PROMIS UE, PF,
and PI domains at each visit. A total of 101 patients agreed
to participate. Of these, 31 patients (31%) did not return
for a followup visit at least 6 weeks after CTR
and were excluded, leaving a final sample of 70 patients
(69%). We compared the PROMIS against region- and
condition-specific PROMs in terms of responsiveness and
concurrent validity. Responsiveness was determined using
Cohen’s d or the effect-size index (ESI). The larger the
absolute value of the ESI, the greater the effect size. Using
the ESI allows surgeons to better quantify the impact of
CTR, with amediumESI (that is, 0.5) representing a visible
clinical change to a careful observer. Concurrent validity
was determined using Spearman’s correlation coefficient
with correlation strengths categorized as excellent (> 0.7),
excellent-good (0.61-0.70), good (0.4-0.6), and poor
(< 0.4). Significance was set a priori at p < 0.05.
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Results Among PROMIS domains, the PI demonstrated
the best responsiveness (ESI = 0.74; 95% CI, 0.39-1.08),
followed by the UE (ESI = -0.66; 95% CI, -1.00 to -0.31).
For theMHQ, the Satisfaction domain had the largest effect
size (ESI = -1.48; 95% CI, -1.85 to -1.09), while for the
BCTQ, the Symptom Severity domain had the best re-
sponsiveness (ESI = 1.54; 95% CI, 1.14-1.91). The
PROMIS UE and PI domains demonstrated excellent-good
to excellent correlations to the total MHQ and BCTQ–
Functional Status scores (preoperative UE to MHQ:
r = 0.68; PI to MHQ: r = 0.74; UE to BCTQ–Functional
Status: r = 0.74; PI to BCTQ–Functional Status: r = 0.67;
all p < 0.001), while the PROMIS PF demonstrated poor
correlations with the same domains (preoperative PF to
MHQ; r = 0.33; UE to BCTQ–Functional Status: r = 0.39;
both p < 0.01).
Conclusions The PROMIS UE and PI domains demon-
strated slightly worse responsiveness than the MHQ and
BCTQ domains that was nonetheless acceptable. The
PROMIS PF domain was unresponsive. All three PROMIS
domains correlated with the MHQ and BCTQ, but the
PROMIS UE and PI domains had notably stronger corre-
lations to the MHQ and BCTQ domains than the PF do-
main did. We feel that the PROMIS UE and PI can be used
to evaluate the clinical outcomes of patients undergoing
CTR, while also providing more robust insight into overall
health status because they are general PROMs. However,
we do not recommend the PROMIS PF for evaluating
patients undergoing CTR.
Level of Evidence Level II, diagnostic study.
Introduction
Recently, there has been an interest in using patient-
reported outcomes measures (PROMs) [1] as the US
healthcare system shifts towards focusing on value—
defined as dollar spent per health outcome achieved [26].
The use of PROMs may help better align orthopaedic
surgeons’ expectations with clinical outcomes [8] and help
surgeons incorporate measures of patient-reported health
into treatment decisions to understand patients’ responses
to different treatments and understand whomight clinically
benefit from a given intervention [23, 29]. Within ortho-
paedic surgery, a number of validated, region-specific
PROMs have frequently been used in patient care [7, 18,
22, 30, 34]. However, more recently, there has been a new
movement towards universal PROMs as the push towards
population health increases. The Patient-reported Outcome
Measurement Information System (PROMIS) is a generic
PROM that incorporates item response theory and com-
puterized adaptive testing [6]. One benefit of the PROMIS
is that it captures constructs that are similar to those of
specialty-specific PROMs [2, 9, 10, 25, 28]. It is also
responsive; that is, the PROMIS’s domains can be used
detect change over time [13, 14, 16, 17, 19]. Although
studies in certain areas of orthopaedic surgery (such as
ACL reconstruction and spine disorders) show that the
PROMIS domains and region-specific scales have com-
parable responsiveness [19, 32], there is still concern that
the PROMIS Physical Function (PF), Upper Extremity
(UE), and Pain Interference (PI) domains are not suffi-
ciently specific to the hand or certain hand procedures such
as carpal tunnel release (CTR). Because of concern that the
PROMIS PF domain is not responsive to hand conditions, a
PROMIS UE physical function scale was developed.
Studies documenting the responsiveness and concurrent
validity of the PROMIS in patients seeking hand care are
needed. An evaluation of responsiveness and concurrent
validity in a subset of patients seeking hand care, such as
those undergoing CTR, will offer much better insight into
common hand conditions. Patients undergoing CTR are an
ideal population to begin such an inquiry in because CTR is
common, with a lifetime prevalence of 3.1% [27], and CTR
is the only hand condition that can be evaluated with both a
region-specific PROM (Michigan Hand Questionnaire
[MHQ]) and a condition-specific PROM (Boston Carpal
Tunnel Questionnaire [BCTQ]). If the PROMIS is equally
responsive and valid as region-specific PROMs, the finan-
cial investment in potentially improved patient care may be
worthwhile, because the PROMIS measures a patient’s
overall health and the impact of carpal tunnel syndrome
(CTS) instead of simply disease-specific effects [15].
Therefore, we asked: (1) Which PROMs demonstrate
high responsiveness among patients undergoing CTR? (2)
Which of the PROMIS domains (PF, UE, and PI) dem-
onstrate concurrent validity with the MHQ and BCTQ
domains?
Patients and Methods
Study Design and Patient Sample
Between November 2014 and October 2016, patients
presenting to a single hand surgeon at a large, urban, aca-
demic medical center who had isolated CTS and wanted to
undergo CTR were asked to participate in this prospective,
institutional review board-approved study. The presence of
CTS was determined by taking the patient’s history and
performing a physical examination, and was confirmed
with EMG testing. A total of 101 patients were willing to
participate. Of these, 31 patients (31%) were removed from
the final sample because they did not attend a followup
clinic visit at least 6 weeks after undergoing CTR. This
left a final sample of 70 patients (69%) for all analyses (Fig.
1). The average age was 61 years (range, 27-86 years) and
the majority were women (46; 66%) (Table 1). Most
patients (43; 61%) had a 6-week followup visit, while the
remainder (27 patients; 39%) had a 3-month followup visit.
The majority of operations were on the right wrist (43
patients; 61%).
Apple iPads (Apple, Cupertino, CA, USA) were used to
gather PROM data; this has been shown to be an efficient
approach in a hand-surgery population [35]. Each patient
completed the following PROMs: the PROMIS PF, PI, and
UE domains; the BCTQ; and the MHQ, and the results
were collated using REDCap (Vanderbilt University,
Nashville, TN, USA). Patients completed all PROMs at
each visit during the study period. To allow for recovery
after CTR, we only included patients with PROM scores
from initial preoperative clinic visits and final followup
clinic visits at 6 weeks or 3 months postoperatively.
Higher PROMIS PF and UE scores indicate better
physical function, while higher PROMIS PI scores denote
increased pain interference or physical limitations sec-
ondary to pain [5]. PROMIS domains follow a population-
based normal distribution, with a mean t-score of 50 and
standard deviation of 10 [11]. Unlike the other PROMs
used in this study, there is no total PROMIS score, because
each domain evaluates a different construct. For the
BCTQ–Total Score (average of the two BCTQ domains–
Functional Status Scale and Symptom Severity Scale),
which has a score ranging from 1 to 5, higher scores in-
dicate worse symptom severity and physical function. For
the MHQ, which has a score ranging from 0 to 100, lower
scores indicate worse overall hand health.
Statistical Analysis
We calculated the patients’ characteristics. We also eval-
uated the three PROMIS domains (UE, PF, PI); eight MHQ
domains (Overall Hand Function, Activities of Daily
Living–One Hand, Activities of Daily Living–Two Hands,
Overall Activities of Daily Living, Ability to Work, Pain,
Aesthetic, and Satisfaction), in addition to the total score;
and two BCTQ domains (Symptom Severity Scale and
Functional Status Scale), in addition to the average of the
two domains (that is, the BCTQ–Total Score).
To evaluate the responsiveness of each PROM domain,
we used Cohen’s d, or the effect-size index (ESI), for all
changes in scores. The absolute value of each ESI was taken
because the size of the effect was of themost interest, not the
direction. The ESI is a frequently used index of change to
judge responsiveness, with higher values indicating im-
proved responsiveness or better ability to detect change [20].
Responsiveness is important to evaluate for any PROM; for
example, if the instrument does not effectively identify clear
clinical improvement after CTR, then we cannot use that
particular PROM to evaluate the success or failure of CTR.
Values of 0.2, 0.5, and greater than 0.8 are considered small,
medium, and large effect sizes, respectively [20]. To put
these values into a clinical perspective, an ESI of 0.5 (that
is, a medium effect size) may be thought of as representing a
true change in patient status that is appreciated by a careful
observer [33]. In the current study, we evaluated the change
between the preoperative visit and longest followup post-
operatively, either 6 weeks or 3 months.
Concurrent validity was evaluated using Spearman’s
correlation coefficients (r) because the assumption of nor-
mality (Shapiro-Wilk test, skewness, kurtosis, and visual
assessment of histograms) was not met for all variables.
Absolute values were used because the strength, not the
direction of the correlation, indicates concurrent validity.
Spearman’s correlation coefficients were calculated for each
preoperative PROMIS domain andMHQdomain (as well as
MHQ–Total Score) and each preoperative PROMIS domain
and BCTQ domain (as well as BCTQ–Total Score).
Spearman’s correlation coefficients were also calculated for
Fig. 1 This diagram illustrates the pathway from the total possible patient sample agreeing
to participate in this prospective study to the final patient sample used for all analyses.
each postoperative PROMIS domain and MHQ domain (as
well asMHQ–Total Score) and each postoperative PROMIS
and BCTQ domain (as well as BCTQ–Total Score). Using
guidelines from a previous study using the PROMIS [31],
we designated the strength of the Spearman’s correlations
for the total PROM scores as follows: excellent (> 0.7),
excellent-good (0.61-0.70), good (0.4-0.6), and poor (< 0.4).
Significance was set a priori at p < 0.05.
Results
Responsiveness of Outcomes Tools
The PI domain of the PROMIS demonstrated the best re-
sponsiveness (ESI = 0.74; 95%CI, 0.39-1.08), followed by
the UE domain (ESI = -0.66; 95% CI, -1.00 to -0.31). For
theMHQ, the Satisfaction domain demonstrated the largest
effect size (ESI = -1.48; 95% CI, -1.85 to -1.09), followed
by the Total Score (ESI = -1.22; 95% CI, -1.58 to -0.84).
For the BCTQ, the Symptom Severity domain demon-
strated the best responsiveness (ESI = 1.54; 95% CI,
1.14-1.91). All PROMs except for the PROMIS PF domain
(ESI = -0.25; 95% CI, -0.59 to 0.08) and MHQ Aesthetic
domain (ESI = 0.02; 95% CI, -0.32 to 0.36) demonstrated
at least a medium effect size at the final followup exami-
nation (Table 2).
Concurrent Validity Among Outcomes Tools
Among the preoperative PROM scores, the PROMIS UE
and PI scores demonstrated concurrent validity (excellent-
good and excellent correlations, respectively) with the
MHQ Total Score (UE: r = 0.68; p < 0.001; PI: r = 0.74;
p < 0.001, but the PROMIS PF score demonstrated a poor
correlation with the MHQ Total Score (r = 0.33; p = 0.006)
(Table 3). Preoperative PROMIS UE scores exhibited
good-to-excellent correlations with all preoperative
MHQ domain scores (range, UE: r = 0.41-0.80; all p <
0.001) except for theMHQAesthetics score (r = 0.24; p =
0.04) (Table 3). Likewise, preoperative PROMIS PI
scores exhibited good to excellent-good correlations with
all preoperative MHQ domain scores (UE: r = 0.53-0.69;
all p < 0.001) except for the MHQ Aesthetics score (r =
0.18; p = 0.15) (Table 3). For the PROMIS PF, correla-
tions with the MHQ domains ranged from poor to good
(PF: r = 0.007-0.48; p = 0.95 to < 0.001) (Table 3).
Among preoperative PROM scores, the PROMIS UE and
PI demonstrated excellent and excellent-good correla-
tions, respectively, with the BCTQ–Functional Status
domain (UE: r = 0.74; p < 0.001; PI: r = 0.67; p < 0.001),
while the PF demonstrated a poor correlation (PF:
r = 0.39; p = 0.001) (Table 3). The PROMIS UE and PI
domains also demonstrated good and excellent-good
correlations, respectively, with the BCTQ–Symptom
Severity scale (UE: r = 0.49; p < 0.001; PI: r = 0.69; p <
0.001), while the PF had a poor correlation (PF: r = 0.04;
p = 0.73) (Table 3).
Among postoperative PROM scores, the PROMIS UE
and PI scores demonstrated concurrent validity (excellent-
good to excellent correlations, respectively) with the MHQ
Total Score (UE: r = 0.65; p < 0.001; PI: r = 0.72; p <
0.001) (Table 4). The PROMIS PF scores had a poor cor-
relation with the MHQ Total Score (r = 0.36; p = 0.002)
(Table 4). Except for the MHQ Aesthetics domain (r =
0.007; p = 0.96), postoperative PROMIS UE scores




Age, years 61 (14)
Sex, female 46 (66%)
Operative side, right 43 (61%)
Hand dominance, right 64 (91%)
Followup
6 weeks 43 (61%)
3 months 27 (39%)





UE -0.66 (-1.00 to -0.31)
PF -0.25 (-0.59 to 0.08)
PI 0.74 (0.39-1.08)
MHQ
Overall Hand Function -0.99 (-1.34 to -0.63)
Activities of Daily Living -0.61 (-0.95 to -0.27)
Activities of Daily Living–Two Hands -0.64 (-0.98 to -0.29)
Overall Activities of Daily Living -0.67 (-1.01 to -0.32)
Ability to Work -0.57 (-0.91 to -0.22)
Pain 1.17 (0.80-1.52)
Aesthetics 0.02 (-0.32 to 0.36)
Satisfaction -1.48 (-1.85 to -1.09)
Total Score -1.22 (-1.58 to -0.84)
BCTQ
BCTQ–Symptom Severity Scale 1.54 (1.14-1.91)
BCTQ–Functional Status Scale 0.84 (0.49-1.19)
BCTQ–Total Score 1.27 (0.90-1.63)
BCTQ = Boston Carpal Tunnel Questionnaire; MHQ = Michigan
HandQuestionnaire; PF= Physical Function; PI = Pain Interference;
PROMIS = Patient-reported Outcome Measurement Information
System; UE = Upper Extremity.
exhibited good to excellent-good correlations with all other
preoperative MHQ domain scores (UE: r = 0.53-0.69; all
p < 0.001) (Table 4). Except for the MHQ Aesthetics do-
main (r = 0.09; p = 0.48), postoperative PROMIS PI scores
exhibited good-to-excellent correlations with all other
preoperative MHQ domain scores (UE: r = 0.54-0.72; all
p < 0.001) (Table 4). For the PROMIS PF, only the cor-
relation with MHQ Overall Hand Function, Activities of
Daily Living–Two Hands, and Overall Activities of Daily
Living was above poor (PF: r = 0.40-0.44; all p < 0.05)
(Table 4). The PROMIS UE and PI domains also demon-
strated excellent and excellent-good correlations, re-
spectively, with the BCTQ–Symptom Severity domain
(UE: r = 0.74; p < 0.001; PI: r = 0.62; p < 0.001), while the
PF domain had a good correlation (PF: r = 0.40; p = 0.008).
Similarly, for the BCTQ–Functional Status scale post-
operatively, the PROMIS UE and PI also demonstrated
excellent and excellent-good correlations, respectively
(UE: r = 0.75; p < 0.001; PI: r = 0.66; p < 0.001). The
PROMIS PF domain had a poor correlation with the
BCTQ–Functional Status domain postoperatively (PF:
r = 0.37; p = 0.002) (Table 4).
Discussion
PROMs, especially generic instruments such as the
PROMIS, are becoming common in orthopaedic clinics with
an increasing interest in value-based health care. In many
orthopaedic settings, the PROMIS, which may add more
value than other PROMs because of its ability to provide
insight into a patient’s overall health in the setting of illness,
has been shown to capture constructs that are similar to those
of more focused PROMs (such as region-specific PROMs)
[2, 9, 10, 25, 28] with comparable responsiveness [13, 16,
17, 19]. However, it is unclear if this is consistent within a
patient population that has a single, common hand condition
(that is, CTS) treated with the same procedure (CTR). The
findings of this study suggest that the PROMIS UE and PI
scores effectively detect change in patients undergoing
CTR; however, region- and disease-specific scales
demonstrated a greater ability to detect change than the
PROMIS did. Overall, we found the PROMIS UE and PI
scales to be moderately responsive and valid in capturing
information on the outcomes of patients undergoing CTR,
while the PROMIS PF is neither responsive nor valid for this
Table 3. Spearman’s correlation coefficient for the preoperative PROMIS, MHQ, and BCTQ domain scores (n = 70)
PROM MHQ or BCTQ domain
PROMIS domain
UE PF PI
MHQ Overall Hand Function 0.52 0.34 0.53
p value < 0.001 0.004 < 0.001
Activities of Daily Living 0.58 0.41 0.56
p value < 0.001 0.001 < 0.001
Activities of Daily Living–Two Hands 0.80* 0.48 0.63*
p value < 0.001 < 0.001 < 0.001
Overall Activities of Daily Living 0.73* 0.45 0.64*
p value < 0.001 < 0.001 < 0.001
Ability to Work 0.65* 0.40 0.69*
p value < 0.001 0.001 < 0.001
Pain 0.41 0.007 0.65*
p value < 0.001 0.950 < 0.001
Aesthetics 0.24 0.21 0.18
p value 0.040 0.080 0.150
Satisfaction 0.45 0.24 0.59
p value < 0.001 0.050 < 0.001
Total Score 0.68* 0.33 0.74*
p value < 0.001 0.006 < 0.001
BCTQ BCTQ–Symptom Severity Scale 0.49 0.04 0.69*
p value < 0.001 0.730 < 0.001
BCTQ–Functional Status Scale 0.74* 0.39 0.67*
p value < 0.001 0.001 < 0.001
*Denotes an excellent to excellent-good correlation. BCTQ = Boston Carpal Tunnel Questionnaire; MHQ = Michigan Hand
Questionnaire; PROM = patient-reported outcomes measure; PROMIS = Patient-reported Outcome Measurement Information
System.
purpose. Thus, we recommend that surgeons use the
PROMIS UE and PI scales rather than the PF when electing
to use the PROMIS for evaluating patients.
Our study’s limitations should be considered when
evaluating our findings. First, the data come from a single
institution and surgeon. While there may be a question of
generalizability, we feel our findings may be applicable to
clinics with similar characteristics (such as an urban tertiary
care center). Nonetheless, validating our findings with an
independent sample would be valuable. Further work may
also evaluate whether our results are consistent with more
rural, community-based centers.
Second, we had a selection bias for two key reasons:
(1) We only included patients who presented pre-
operatively and at 6 weeks or 3 months postoperatively and
(2) although 101 patients were ultimately enrolled in our
study, we approached every patient with a diagnosis of
CTS and not everyone was willing to participate. It is
possible that those willing to enroll were more invested in
their care and/or had other traits or resources that would
impact PROMs. Additionally, because patients who
returned to the clinic before 6 weeks after surgery were not
included, we could be missing patients who recovered to a
greater extent. However, we feel our study was not sub-
stantially affected by these factors because this bias is
consistent across all PROMs, and we did not evaluate
clinical outcomes but the performance of one PROM
against others at the final timepoint at which patients felt
they needed to see a hand surgeon.
Third, the study had two postoperative timepoints.
While this may have affected the size of the ESI for each
PROMbecause more or less time had passed for a patient to
recover, it does not substantially affect our study findings.
This is because our goal was not to evaluate clinical out-
comes over time but to compare the ability of each PROM
to capture change against one other. Indeed, although the
times differ, the length of followup affects all PROMs
equally; thus, comparing responsiveness is still valid.
Fourth, the severity of CTS may vary, which could
impact the amount of possible clinical improvement.
However, similar to the third limitation, we are not as
worried about this limitation because this study did not
evaluate clinical outcomes, and all PROMs used for com-
parison were from the same patient population.
Table 4. Spearman’s correlation coefficients for the postoperative PROMIS, MHQ, and BCTQ domain scores (n = 70)
PROM MHQ or BCTQ domain
PROMIS domain
UE PF PI
MHQ Overall Hand Function 0.57 0.40 0.65*
p value < 0.001 < 0.001 < 0.001
Activities of Daily Living 0.61* 0.37 0.61*
p value < 0.001 0.002 < 0.001
Activities of Daily Living–Two Hands 0.69* 0.45 0.66*
p value < 0.001 < 0.001 < 0.001
Overall Activities of Daily Living 0.69* 0.44 0.67*
p value < 0.001 < 0.001 < 0.001
Ability to Work 0.64* 0.35 0.72*
p value < 0.001 0.003 < 0.001
Pain 0.54 0.17 0.60*
p value < 0.001 0.170 < 0.001
Aesthetics 0.007 0.05 0.09
p value 0.960 0.670 0.480
Satisfaction 0.53 0.38 0.54
p value < 0.001 0.001 < 0.001
Total Score 0.65* 0.36 0.72*
p value < 0.001 0.002 < 0.001
BCTQ BCTQ 0.74* 0.40 0.62*
p value < 0.001 < 0.001 < 0.001
BCTQ–Functional Status 0.75* 0.37 0.66*
p value < 0.001 0.002 < 0.001
*Denotes excellent-good to excellent correlations. BCTQ = Boston Carpal Tunnel Questionnaire; MHQ = Michigan Hand
Questionnaire; PROM = patient-reported outcomes measure; PROMIS = Patient-reported Outcome Measurement Information
System.
Lastly, our patients were informed that the PROMs
would be used for research. Although this may have im-
pacted how the patients completed the questionnaires,
previous research on this subject has shown that patients do
not tend to change PROM answers, even if they are aware
that the scores will be used for research or clinical care [4].
Although the PROMIS UE and PI domains had accept-
able responsiveness in evaluating patients with CTS un-
dergoing CTR at the final followup, they were not as
responsive as the MHQ and BCTQ. The PROMIS PF was
not reasonably responsive in the same patient population.
Previous research has shown that the PROMIS PF, UE, and
PI domains in patients with hand and upper-extremity dis-
orders are responsive [17]. Indeed, the study showed large
effect sizes (ESI, 0.80-1.48) in patients with hand and upper-
extremity disorders [17]. Thesefindings demonstrate that the
PROMIS domains were slightly more responsive in a gen-
eral hand and upper-extremity population than in a specific
population of patients with CTS undergoing CTR. This
suggests that not all hand and upper-extremity disorders are
the same. Another study has examined how PROMIS
domains respond to CTR compared with the MHQ and
BCTQ at different timepoints postoperatively [21]. The
authors noted that the PROMIS UE had a similar but weaker
responsiveness at each postoperative timepoint (that is, the 1-
week, 6-week, and 3-month timepoints), while the PROMIS
PI did not respond at 1 week postoperatively but at the 6-
week and 3-month followup timepoints [21]. The PROMIS
PF did not demonstrate good responsiveness at any of these
timepoints [21]. Although our study differs because we
assessed responsiveness at least 6 weeks after CTR to allow
for at least moderate recovery and only at the patient’s final
followup visit, we found similar results. Indeed, based on the
ESI values, the PROMIS UE and PI show a lower ability to
detect change in patients with CTS than theMHQ and BCTQ
did, although they were comparable. This is to be expected,
because the MHQ and BCTQ were specifically designed to
evaluate an anatomic region and disease process, while
PROMIS domains aremeant to capture data on overall health.
The finding that the PROMIS UE and PI can detect change at
the final followup visit after CTR—even moderately—in
patientswith such a limited, neuropathic hand condition raises
the question of how specific a disease process can be before a
PROMIS domain does not capture change.
The PROMIS UE and PI domains demonstrated stron-
ger correlations, in general, with the MHQ and BCTQ
domains in both the preoperative and postoperative time
periods than the PF did. Studies of patients with hand and
upper-extremity conditions showed there was concurrent
validity between the PROMIS PF and UE and DASH and
QuickDASH (the validated shortened version of the
DASH) [2, 24]. However, we did not find that the PROMIS
PF had concurrent validity with many of the MHQ
domains, which are region-specific and similar to the
DASH and QuickDASH. This difference may be because
of our focus on a single condition and its treatment (that is,
patients with CTS undergoing CTR) or because of the type
of hand conditions we evaluated (such as neuropathic).
Given our results, we suggest using the PROMIS UE in-
stead of the PROMIS PF in patients with CTS whenever
possible. If a generic PROM is preferred, we feel it is also
reasonable to use the PROMIS UE instead of the PROMIS
PF in patients with all types of hand and wrist conditions
until additional research is performed to determine any
differences between various hand conditions. For example,
future research is needed to determine whether our findings
would be consistent in patients with basal joint arthritis or
traumatic conditions (such as distal radius fracture) as well.
This study demonstrated that the PROMIS UE and PI are
responsive and show concurrent validity in patients un-
dergoing CTR. Region- and disease-specific scales both
showed better responsiveness, with theMHQSatisfaction and
BCTQ Symptom Severity scales demonstrating the highest
ESI scores. Our evaluation of concurrent validity showed that
the PROMIS UE and PI scales are acceptable for evaluating
patients undergoing CTR. However, we do not recommend
using the PROMISPF for patients undergoing CTRbecause it
is not responsive and does not correlate strongly with region-
or condition-specific PROMs. As expected, region- and
condition-specific PROMs tend to capture data on a specific
anatomic area or condition slightly better than general PROMs
do; however, it is promising that a global PROM competes
well with these instruments. Ultimately, using a global PROM
such as the PROMIS may be more advantageous than region-
and condition-specific PROMs as we shift our focus to pop-
ulation health, general wellbeing, and value-based medicine.
This is because the PROMIS is normalized to the general
population and offers a more complete picture of a patient’s
overall health. There is a great opportunity in day-to-day
clinical medicine to use these PROMIS domains, as well as
others that capture more psychosocial elements of health such
as self-resiliency, to inform surgeons on a patient’s overall
health status and how best to council or treat him or her.
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